Vax-sode Spray
NDC Package 83027-0153-1
Package Information
Vax-sode (thuja occidentalis, calcarea carbonica, silicea, salmonella typhi nosode, serum anguillae, bacillus tetani, malandrinum, morbillinum, parotidinum, rubella nosode, yersinia enterocolitica) sprays is • Adults: 2 to 3 sprays orally, three times daily. This formulation utilizes a spray delivery system. Marketed by Nutritional Specialties, Inc., this product is identified by NDC 83027-0153.
Identification & Billing
Clinical Specifications
- ANGUILLA ROSTRATA BLOOD SERUM 18 [hp_X]/mL
- CLOSTRIDIUM TETANI 30 [hp_X]/mL
- MEASLES VIRUS 30 [hp_X]/mL
- MUMPS VIRUS 30 [hp_X]/mL
- OYSTER SHELL CALCIUM CARBONATE, CRUDE 9 [hp_X]/mL
- RUBELLA VIRUS 30 [hp_X]/mL
- SALMONELLA ENTERICA ENTERICA SEROVAR TYPHI 18 [hp_X]/mL
- SILICON DIOXIDE 9 [hp_X]/mL
- THUJA OCCIDENTALIS LEAFY TWIG 6 [hp_X]/mL
- VACCINIA VIRUS 30 [hp_X]/mL
- YERSINIA ENTEROCOLITICA 30 [hp_X]/mL
Regulatory & Marketing
Hierarchy Structure
- 83027 - Nutritional Specialties, Inc.
- 83027-0153 - Vax-sode
- 83027-0153-1 - 60 mL in 1 BOTTLE, SPRAY
- 83027-0153 - Vax-sode
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 83027-0153-1 identifies a specific commercial package of 60 ml in 1 bottle, spray of Vax-sode, a human over the counter drug labeled by Nutritional Specialties, Inc.. This spray is formulated for oral use and contains anguilla rostrata blood serum; clostridium tetani; measles virus; mumps virus; oyster shell calcium carbonate, crude; rubella virus; salmonella enterica enterica serovar typhi; silicon dioxide; thuja occidentalis leafy twig; vaccinia virus; yersinia enterocolitica as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Nutritional Specialties, Inc. on September 22, 2025. The current certification is valid through December 31, 2026.
How is this Nutritional Specialties, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 83027015301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.